Loading...
By Kelly Young
Edited by Jaye Elizabeth Hefner, MD
Statin intolerance following myocardial infarction (MI) is associated with increased risks for recurrent MI and coronary heart disease (CHD) events, according to a retrospective study in the Journal of the American College of Cardiology.
Researchers studied 57,000 Medicare beneficiaries who were prescribed statins following an MI. Nearly 2% were deemed intolerant to statins in the year following treatment initiation based on:
switching to a lower dose or discontinuing statins, plus starting ezetimibe;
being diagnosed with rhabdomyolysis or an antihyperlipidemic event, with statin down-titration or discontinuation; or
receiving three or more different statins.
During a median 2 years' follow-up, statin-intolerant patients were more likely than highly adherent patients to experience recurrent MI (41 vs. 30 events per 1000 person-years) and CHD events (63 vs. 44 events per 1000).
NEJM Journal Watch Cardiology associate editor Dr. Joel M. Gore comments: "This study underscores the importance of following evidence-based guidelines and educating patients on the well proven benefit of statins. Frank discussions with patients about the consequences of not adhering to evidence-based, guideline-recommended medical therapy may be necessary."
Comment
LINK(S):
JACC article (Free abstract)
JACC editorial (Subscription required)
Background: NEJM Journal Watch Cardiology coverage of statin intolerance (Free)